Triple
T16952538
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Daypro |
E411217
|
entity |
| Predicate | mayInteractWith |
P3970
|
FINISHED |
| Object | methotrexate |
E242406
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: methotrexate | Statement: [Daypro, mayInteractWith, methotrexate]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: methotrexate Context triple: [Daypro, mayInteractWith, methotrexate]
-
A.
methotrexate
chosen
Methotrexate is a disease-modifying antirheumatic drug (DMARD) commonly used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and certain cancers by inhibiting folate-dependent cell proliferation.
-
B.
sulfasalazine
Sulfasalazine is an anti-inflammatory drug commonly used to treat rheumatoid arthritis and inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease.
-
C.
Remicade
Remicade is a widely used monoclonal antibody biologic (infliximab) prescribed to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
-
D.
Rituxan
Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
-
E.
Kevzara
Kevzara is a prescription monoclonal antibody medication (sarilumab) used to treat adults with moderate to severe rheumatoid arthritis by targeting the interleukin-6 (IL-6) receptor.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d886c9c9d481909afe222093641cae |
completed | April 10, 2026, 5:12 a.m. |
| NER | Named-entity recognition | batch_69e3d0197f308190af7185fc9cc7a6e9 |
completed | April 18, 2026, 6:40 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a00d46213b08190b33b48d12bc795d1 |
completed | May 10, 2026, 6:54 p.m. |
Created at: April 10, 2026, 5:31 a.m.